86
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Glycophenotype of breast and prostate cancer stem cells treated with thieno[2,3-b]pyridine anticancer compound

, , , , , , & show all
Pages 759-769 | Published online: 14 Mar 2017

References

  • MayCDSphyrisNEvansKWWerdenSJGuoWManiSAEpithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progressionBreast Cancer Res2011131 20221392411
  • CastilloVValenzuelaRHuidobroCContrerasHRCastellonEAFunctional characteristics of cancer stem cells and their role in drug resistance of prostate cancerInt J Oncol2014453 985 99424990514
  • Al-HajjMWichaMSBenito-HernandezAMorrisonSJClarkeMFProspective identification of tumorigenic breast cancer cellsProc Natl Acad Sci U S A20031007 3983 398812629218
  • Llombart-CussacABermejoBVillanuevaCSOLTI NeoPARP: a phase II randomized study of two schedules of iniparib plus paclitaxel versus paclitaxel alone as neoadjuvant therapy in patients with triple-negative breast cancerBreast Cancer Res Treat20151542 351 35726536871
  • CorcoranCRaniSO’BrienKDocetaxel-resistance in prostate cancer: evaluating associated phenotypic changes and potential for resistance transfer via exosomesPLoS One2012712 e5099923251413
  • NoharaKWangFSpiegelSGlycosphingolipid composition of MDA-MB-231 and MCF-7 human breast cancer cell linesBreast Cancer Res Treat1998482 149 1579596486
  • RavindranathMHMuthugounderSPresserNYeXBrosmanSMortonDLEndogenous immune response to gangliosides in patients with confined prostate cancerInt J Cancer20051163 368 37715818621
  • OlivaJPValdesZCasacoAClinical evidences of GM3 (NeuGc) ganglioside expression in human breast cancer using the 14F7 monoclonal antibody labelled with (99m)TcBreast Cancer Res Treat2006962 115 12116322892
  • ProkazovaNVSamovilovaNNGrachevaEVGolovanovaNKGanglioside GM3 and its biological functionsBiochemistry (Mosc)2009743 235 24919364317
  • DykstraMCherukuriASohnHWTzengSJPierceSKLocation is everything: lipid rafts and immune cell signalingAnnu Rev Immunol200321 457 48112615889
  • NeameSJUffCRSheikhHWheatleySCIsackeCMCD44 exhibits a cell type dependent interaction with triton X-100 insoluble, lipid rich, plasma membrane domainsJ Cell Sci1995108Pt 9 3127 31358537452
  • KielyJMHuYGarcia-CardenaGGimbroneMAJrLipid raft localization of cell surface E-selectin is required for ligation-induced activation of phospholipase C gammaJ Immunol20031716 3216 322412960351
  • BarthelSRGavinoJDDeschenyLDimitroffCJTargeting selectins and selectin ligands in inflammation and cancerExpert Opin Ther Targets20071111 1473 149118028011
  • BabinaISMcSherryEADonatelloSHillADHopkinsAMA novel mechanism of regulating breast cancer cell migration via palmitoylation-dependent alterations in the lipid raft affiliation of CD44Breast Cancer Res2014161 R1924512624
  • TagamiSInokuchi JiJKabayamaKGanglioside GM3 participates in the pathological conditions of insulin resistanceJ Biol Chem20022775 3085 309211707432
  • LeungEHungJMBarkerDReynissonJThe effect of a thieno[2,3-b] pyridine PLC-[gamma] inhibitor on the proliferation, morphology, migration and cell cycle of breast cancer cellsMedChemComm201451 99 106
  • FengLReynisdottirIReynissonJThe effect of PLC-gamma2 inhibitors on the growth of human tumour cellsEur J Med Chem201254 463 46922698703
  • HungJMArabshahiHJLeungEReynissonJBarkerDSynthesis and cytotoxicity of thieno[2,3-b]pyridine and furo[2,3-b]pyridine derivativesEur J Med Chem201486 420 43725194934
  • ArabshahiHJLeungEBarkerDReynissonJThe development of thieno[2,3-b]pyridine analogues as anticancer agents applying in silico methodsMedChemComm201452 186 191
  • ReynissonJCourtWO’NeillCThe identification of novel PLC-γ inhibitors using virtual high throughput screeningBioorg Med Chem2009178 3169 317619303309
  • ReynissonJJaiswalJKBarkerDEvidence that phospholipase C is involved in the antitumour action of NSC768313, a new thieno[2,3-b] pyridine derivativeCancer Cell Int201616 1826966420
  • ArabshahiHJvan RensburgMPilkingtonLIA synthesis, in silico, in vitro and in vivo study of thieno[2,3-b]pyridine anticancer analoguesMedChemComm2015611 1987 1997
  • MosmannTRapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assaysJ Immunol Methods1983651–2 55 636606682
  • RossAEEmadiAMarchionniLDimeric naphthoquinones, a novel class of compounds with prostate cancer cytotoxicityBJU Int20111083 447 45421176082
  • YangMYWangCJChenNFHoWHLuFJTsengTHLuteolin enhances paclitaxel-induced apoptosis in human breast cancer MDA-MB-231 cells by blocking STAT3Chem Biol Interact2014213 60 6824525192
  • ParkSYKimMJParkSACombinatorial TGF-beta attenuation with paclitaxel inhibits the epithelial-to-mesenchymal transition and breast cancer stem-like cellsOncotarget2015635 37526 3754326462028
  • HandaKHakomoriSICarbohydrate to carbohydrate interaction in development process and cancer progressionGlycoconj J2012298–9 627 63722610315
  • ChungTWChoiHJKimSJThe ganglioside GM3 is associated with cisplatin-induced apoptosis in human colon cancer cellsPLoS One201495 e9278624829158
  • BremerEGSchlessingerJHakomoriSGanglioside-mediated modulation of cell growth. Specific effects of GM3 on tyrosine phosphorylation of the epidermal growth factor receptorJ Biol Chem19862615 2434 24402418024
  • ToledoMSSuzukiEHandaKHakomoriSCell growth regulation through GM3-enriched microdomain (glycosynapse) in human lung embryonal fibroblast WI38 and its oncogenic transformant VA13J Biol Chem200427933 34655 3466415143068
  • WellsASoutoJCSolavaJKassisJBaileyKJTurnerTLuteinizing hormone-releasing hormone agonist limits DU-145 prostate cancer growth by attenuating epidermal growth factor receptor signalingClin Cancer Res200284 1251 125711948140
  • DavidsonNEGelmannEPLippmanMEDicksonRBEpidermal growth factor receptor gene expression in estrogen receptor-positive and negative human breast cancer cell linesMol Endocrinol198713 216 2233502607
  • ToledoMSSuzukiEHandaKHakomoriSEffect of ganglioside and tetraspanins in microdomains on interaction of integrins with fibroblast growth factor receptorJ Biol Chem200528016 16227 1623415710618
  • MiLYEttensonDSEdelmanERPhospholipase C-delta extends intercellular signalling range and responses to injury-released growth factors in non-excitable cellsCell Prolif2008414 671 69018616695
  • YangYRFolloMYCoccoLSuhPGThe physiological roles of primary phospholipase CAdv Biol Regul2013533 232 24124041464
  • SuhPGParkJIManzoliLMultiple roles of phosphoinositide-specific phospholipase C isozymesBMB Rep2008416 415 43418593525
  • LomasneyJWChengHFKobayashiMKingKStructural basis for calcium and phosphatidylserine regulation of phospholipase C delta1Biochemistry20125111 2246 225722385159
  • MarkoticACulicVCKurirTTOxygenation alters ganglioside expression in rat liver following partial hepatectomyBiochem Biophys Res Commun20053301 131 14115781242
  • CazetAJulienSBobowskiMBurchellJDelannoyPTumour-associated carbohydrate antigens in breast cancerBreast Cancer Res2010123 20420550729
  • ZenKCuiLBZhangCYLiuYCritical role of mac-1 sialyl Lewis x moieties in regulating neutrophil degranulation and transmigrationJ Mol Biol20073741 54 6317919658
  • ZenKLiuDQGuoYLCD44v4 is a major E-selectin ligand that mediates breast cancer cell transendothelial migrationPLoS One200833 e182618350162
  • GengYChandrasekaranSHsuJWGidwaniMHughesADKingMRPhenotypic switch in blood: effects of pro-inflammatory cytokines on breast cancer cell aggregation and adhesionPLoS One201381 e5495923372803
  • HuangSBijangi-VishehsaraeiKSaadatzadehMRSafaARHuman GM3 synthase attenuates axol-triggered apoptosis associated with downregulation of caspase-3 in ovarian cancer cellsJ Cancer Ther201235 504 51025893133